Global Ai & Big Data In Vaccines Market Is Projected To Reach The Value Of $117.81 Billion By 2030 X Herald
(MENAFN- Ameliorate Digital Consultancy) According to the latest report by Virtue Market Research, in 2022, the Global AI & Big Data in Vaccines Market was valued at $10.3 billion, and is projected to reach a market size of $117.81 billion by 2030. Over the forecast period of 2023-2030, market is projected to grow at a CAGR of 35.61%.A prominent long-term driver propelling the global AI & Big Data in vaccines market is the increasing need for precision medicine and personalized healthcare solutions. As the understanding of genetics and individual variations in disease susceptibility deepens, the demand for tailored vaccines rises. AI and Big Data analytics play a vital role in deciphering complex genetic data, enabling the development of targeted vaccines that are more effective and exhibit fewer adverse effects.
However, the emergence of the COVID-19 pandemic in recent years significantly impacted the vaccines industry. The urgency to develop vaccines against the novel coronaviexpedited the adoption of AI and Big Data solutions. These technologies facilitated rapid data analysis, accelerating vaccine development, clinical trials, and distribution strategies. The pandemic underscored the critical role of AI and Big Data in crisis response, prompting increased investments and collaborative efforts within the industry.
In the short term, an important driver bolstering the AI & Big Data in vaccines market is the growing foon predictive analytics for vaccine demand forecasting. As vaccine production and distribution become more globalized, accurate predictions of demand become crucial to prevent shortages and wastage. AI algorithms analyze varifactors, such as disease outbreaks, population demographics, and healthcare trends, to predict future vaccine needs accurately.
Amidst these dynamics, a significant opportunity arises from the integration of real-time monitoring and AI-powered surveillance systems. These systems can track vaccine distribution, patient outcomes, and adverse reactions, enhancing safety and enabling rapid response to potential concerns. This approach ensures efficient post-vaccination monitoring and reinforces public trust in vaccination programs.
An observable trend within the AI & Big Data in vaccines industry is the utilization of natural language processing (NLP) for vaccine research. NLP algorithms analyze vast amounts of scientific literature and medical data to extract relevant insights, leading to faster identification of potential vaccine candidates and treatment strategies. This trend expedites the research and development process, facilitating collaboration among researchers and optimizing knowledge dissemination.
Request Sample Brochure @
Segmentation Analysis:
The Global AI & Big Data in Vaccines Market segmentation includes:
By Deployment Mode: On-Premise, Cloud, and Hybrid
The cloud computing segment has emerged as the largest growing trend within the global AI & Big Data in vaccines market. The seamless scalability, cost-efficiency, and accessibility offered by cloud platforms have captured the attention of companies seeking to optimize their vaccine-related data processes. Cloud solutions empower companies to handle vast volumes of data generated during vaccine research, clinical trials, and distribution with enhanced agility. Recent developments showcase the adoption of cloud-based analytics tools that enable real-time data processing and collaborative research, positioning the cloud segment as a fundamental driver in reshaping the industry's data infrastructure.
The hybrid computing segment stands out as the fastest growing trend in the global AI & Big Data in vaccines market. Companies are increasingly recognizing the need for a flexible and secure infrastructure that combines on-premises data management with cloud capabilities. Hybrid solutions offer a balanced approach, allowing companies to capitalize on the benefits of both local data control and cloud scalability. This trend has gained momentum as companies prioritize data privacy, regulatory compliance, and data governance, especially in the sensitive realm of vaccine development and healthcare. Recent developments highlight the integration of AI-powered hybrid platforms that enable seamless data sharing while maintaining stringent security protocols, driving the rapid growth of the hybrid segment within the industry.
By End-User: Pharmaceuticals, Government Agencies, Healthcare Institutions, Research Institutions, and Others
Healthcare institutions have emerged as the largest growing segment in the global AI & Big Data in vaccines market, owing to their pivotal role in vaccine distribution, patient care, and public health management. These institutions harness AI and Big Data to streamline vaccine administration, monitor patient responses, and optimize healthcare services. The integration of AI-powered predictive models aids in identifying high-risk populations and tailoring vaccination strategies. Recent developments showcase collaborations between healthcare institutions and technology providers to create sophisticated data-driven platforms that enhance vaccine rollout efficiency and effectiveness, solidifying their significance in shaping the market.
Research institutions stand out as the fastest growing segment in the global AI & Big Data in vaccines market, driven by their profound impact on vaccine discovery and development. These institutions leverage AI algorithms and data analytics to accelerate the identification of potential vaccine candidates, predict their efficacy, and optimize clinical trial design. The application of Big Data analytics facilitates the analysis of diverse datasets, aiding in the understanding of immune responses and disease trends. Recent developments underscore partnerships between research institutions, pharmaceutical companies, and technology firms to create collaborative ecosystems that expedite vaccine research and innovation, marking the rapid growth of research institutions as a pivotal trend within the industry.
Customize The Report According to Your Needs @
By Region:
North America has positioned itself as the largest growing market in the global AI & Big Data in vaccines industry due to its robust technological infrastructure, advanced healthcare ecosystem, and significant investments in research and development. Countries like the United States and Canada are at the forefront of adopting AI and Big Data solutions across healthcare domains, including vaccines. The region's established collaborations between technology firms, research institutions, and healthcare providers have accelerated the integration of AI-driven analytics into vaccine-related processes. Recent developments highlight partnerships between pharmaceutical giants and tech innovators to enhance data-driven vaccine development and distribution strategies, solidifying North America's prominence in driving market growth.
The Asia Pacific region has emerged as the fastest growing market in the global AI & Big Data in vaccines industry, propelled by its expanding healthcare landscape, rapid technological adoption, and increasing demand for advanced healthcare solutions. Countries like China and India are leading this growth trajectory, leveraging their large populations and growing healthcare investments. The region's foon telemedicine, mobile health, and digital health initiatives aligns well with the integration of AI and Big Data into vaccine management. Recent developments emphasize collaborative efforts between governments, technology companies, and healthcare providers to harness AI-powered analytics for efficient vaccine distribution, remote patient monitoring, and data-driven healthcare decisions, establishing Asia Pacific as a dynamic force in driving industry expansion.
Europe holds a significant role in the global AI & Big Data in vaccines industry due to its robust healthcare infrastructure, emphasis on research, and technological innovation. Countries like Germany, France, and the United Kingdom are notable contributors, leveraging their advanced healthcare systems and research institutions to drive market growth. The region's foon data privacy regulations and ethical AI adoption further positions it as a leader in responsible AI-driven healthcare solutions. Recent developments highlight collaborations between European healthcare institutions and technology firms to create data-sharing networks for vaccine research and surveillance, underscoring Europe's prominence in shaping the industry's progress.
Latin America presents emerging market potential in the global AI & Big Data in vaccines industry, driven by increasing healthcare awareness, digital transformation, and growing investment in healthcare infrastructure. Countries like Brazil and Mexare leading this growth, embracing telehealth solutions and digital healthcare initiatives. The region's diverse population and healthcare disparities create opportunities for AI-powered solutions to bridge gaps in vaccine distribution and patient care. Recent developments emphasize partnerships between governments, healthcare providers, and technology startups to deploy AI-driven tools for vaccine management and public health interventions, positioning Latin America as an evolving force in driving industry development.
The Middle East and Africa region showcases evolving healthcare dynamics in the global AI & Big Data in vaccines industry. Nations like the United Arab Emirates and South Africa are witnessing growth driven by a combination of technological adoption and investments in healthcare innovation. The region's foon digital health transformation and telemedicine aligns well with AI and Big Data integration. Recent developments underscore partnerships between regional governments, international organizations, and technology providers to deploy AI-powered analytics for vaccine tracking, public health management, and healthcare service optimization, highlighting the Middle East and Africa's evolving role in shaping the industry landscape.
Latest Industry Developments:
Purchase Full Report @
About Us:
"Virtue Market Research stands at the forefront of strategic analysis, empowering businesses to navigate complex market landscapes with precision and confidence. Specializing in both syndicated and bespoke consulting services, we offer in-depth insights into the ever-evolving interplay between global demand and supply dynamics. Leveraging our expertise, businesses can identify emerging opportunities, discern critical trends, and make decisions that pave the way for future success."
Contact Us:
Virtue Market Research
Kumar Plaza, #103, SRPF Rd, Ramtekadi, Pune, Maharashtra 411013, India
E-mail:
Phone: +1-917 436 1025
MENAFN30082023004660010643ID1106987956
The Global AI Voice Cloning Market Size Is Expected To Reach $7.9 Billion By 2030, Rising At A Market Growth Of 25.2% CAGR During The Forecast Period
ReportLinker
AI dubbing is a new trend that enables production businesses and content creators to translate their work for worldwide markets without hiring voice actors from other countries, therefore, the Media & Entertainment sector is expected to capture approximately 2/5th share of the market by 2030.
Artificial intelligence (AI) enables impaired persons to fully exploit voice cloning technology. People with disabilities like Amyotrophic Lateral Sclerosis (ALS), Huntington's illness, autism, traumatic brain injuries, apraxia, and those who can no longer use their voice can benefit from the capacity to clone a disabled person's voice. Before their voice is lost, people can use voice cloning to save it. A donor's filter is combined with a few seconds of the recipient's vowel sound captured by the technology to create a voice similar to the recipients. These services are especially helpful for folks with trouble pronouncing words or poor communication skills. Today, a huge range of assistive technology makes it possible for almost everyone to utilize information technology (IT). In the future assistive technologies may significantly depend on AI and ML due to the rapidly aging population. These innovations help those who have vision problems, elderly people, or people who have mobility issues. These gadgets' usability and efficiency are improved by AI voice cloning, which enables them to deliver tailored and natural voice responses. Hence, the increasing use of assistive technologies utilizing AI voice cloning will propel the expansion of the market in the coming years.
However, content producers and musicians are in danger of impersonation and fraud due to how quickly thieves can train AI voice cloning technology to learn certain sounds. These incidents raise the issue of whether or not voice copyright should be granted to artists and content producers. Additionally, because identity theft may occur more likely, people's livelihoods are in danger. Due to the ability of criminals to get around voice-based authentication methods, it puts cybersecurity and privacy at risk. Throughout the projection period, these factors are anticipated to limit market growth.
Component Outlook
Based on component, the market is characterized into software and services. The software segment garnered the highest revenue share in the market in 2022. Due to advancements in speech synthesis, deep learning, and voice conversion techniques, AI voice cloning solutions are developing quickly. The current advancements in this area are enhancing voice quality, enabling personalization, supporting accented speech and multilingualism, and investigating real-time voice conversion abilities. AI voice cloning technologies are anticipated to become increasingly important as technology advances in several sectors, including communication, human-computer interaction, and entertainment.
Application Outlook
By application, the market is divided into gaming, advertising, assistive technologies, chatbots & virtual assistants, audiobooks & podcasting, and others. The assistive technologies segment procured a promising growth rate in the market in 2022. For people who cannot talk or struggle with verbal communication, AI voice cloning can provide customized voices. The AI model can be trained using the person's prior voice recordings or by employing a voice similar to theirs, enabling them to communicate more truthfully. Real-time voice cloning systems are being developed by researchers, giving people instant access to their distinctive synthetic speech during phone calls, video conferences, and live interactions.
Deployment Mode Outlook
On the basis of deployment mode, the market is classified into on-premise and cloud. The on-premise segment acquired the largest revenue share in the market in 2022. Businesses may use on-premise solutions to safeguard their intellectual property if they view their voice cloning algorithms and models as valuable assets. They can keep full control of their voice cloning technology as well as prevent any possible breaches or unwanted access by keeping the entire process internal. Organizations have more freedom to modify and perfect their voice cloning models in accordance with particular needs because of on-premise AI voice cloning solutions.
Vertical Outlook
Based on vertical, the market is segmented into media & entertainment, healthcare & life sciences, education & e-learning, and others. The healthcare and life sciences segment recorded a substantial revenue share in the market in 2022. Artificial intelligence voice cloning technology is being adopted by the healthcare sector to enhance patient care as well as automate administrative work. Professionals in these fields must interact with their clients in order to gain their trust. The use of AI voice cloning is becoming extremely important, especially for online users who are healthcare and social service professionals.
Regional Outlook
Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment garnered a considerable growth rate in the market in 2022. Many businesses in this region are funding the development, research, and commercialization of AI voice cloning. Regional market expansion is being supported by partnerships between tech firms, academic institutions, and business stakeholders.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Google LLC (Alphabet Inc.), Microsoft Corporation, Descript, Inc., LumenVox LLC, Amazon.Com, Inc., Baidu, Inc., CandyVoice SAS, iSpeech, Inc., and CereProc Ltd.
Scope of the Study
Market Segments covered in the Report:
By Component
• Software
• Services
By Application
• Podcasting & Audiobooks
• Advertising
• Gaming
• Chatbots & Virtual Assistants
• Assistive Technologies
• Others
By Deployment Mode
• On-premise
• Cloud
By Vertical
• Media & Entertainment
• Healthcare & Life Sciences
• Education & E-Learning
• Others
By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled
• IBM Corporation
• Google LLC (Alphabet Inc.)
• Microsoft Corporation
• Descript, Inc.
• LumenVox LLC
• Amazon.Com, Inc.
• Baidu, Inc.
• CandyVoice SAS
• iSpeech, Inc.
• CereProc Ltd.
Unique Offerings
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization freeRead the full report: https://www.Reportlinker.Com/p06487589/?Utm_source=GNW
About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Story continues
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001The Bull Market In Artificial Intelligence Is Just Beginning: 2 Top AI Stocks To Buy Now And Hold For The Next Decade
Artificial intelligence (AI) has the potential to reshape the global economy in the coming decade. Businesses of all sizes are seeking the means to harness the power of this game-changing technology, and they're willing to pay up to do so.
That's great news for the following two AI leaders, both of which are likely to deliver handsome rewards to their shareholders in the coming years.
Palantir TechnologiesThe tremendous popularity of ChatGPT and other generative AI applications is driving companies to see how they can integrate these tantalizing technologies into their own operations. Palantir Technologies (PLTR 6.04%) wants to help these businesses make the most of the large language models that power ChatGPT and other leading AI apps.
It's well positioned to do so, thanks to its advanced machine-learning technology and decades of experience working with highly sensitive information as a defense contractor.
CEO Alex Karp sees "an infinite market" for Palantir's AI tools. Military customers and other government agencies rely on Palantir to maintain their informational superiority. As a recent example, the U.S. Special Operations Command in June awarded Palantir a multiyear contract worth up to $463 million to bolster its decision-making capabilities.
Businesses, meanwhile, are partnering with Palantir to strengthen their data analysis. Healthcare titan Novartis, for one, is working with Palantir to accelerate its research and development.
In all, Palantir's customer count leaped 38% year over year to 421 in the second quarter. That drove a 13% rise in the cloud-data expert's revenue to $533 million, and a 52% surge in its billings -- an important indicator of future growth -- to $603 million.
Better still, the $285 million in adjusted free cash flow in the first six months of 2023 boosted its cash and investments to over $3 billion as of the end of June, which prompted its board of directors to authorize a $1 billion share repurchase program.
As a profitable, cash-generating enterprise with highly regarded machine-learning tech, Palantir is well placed to claim a sizable share of the fast-growing AI market in the years ahead.
NvidiaNo list of artificial intelligence stocks is complete without mention of Nvidia (NVDA 0.98%). The semiconductor juggernaut dominates the explosive market for AI accelerators, the cutting-edge chips upon which the most powerful artificial intelligence applications are built.
A tidal wave of capital is flowing toward promising AI projects. Major cloud computing providers, such as Microsoft and Alphabet, are ramping up their infrastructure investments in response to booming demand.
The data center market is projected to exceed $600 billion by 2030, up from $263 billion in 2022, according to research company Prescient & Strategic Intelligence. UBS analyst Timothy Arcuri expects Nvidia's best-in-class AI chips to enable it to capture as much as 25% of this rapidly expanding industry by 2024, up from 6% in 2022.
Business is already booming. Nvidia's revenue soared 101% year over year to $13.5 billion in the quarter ended July 30. And its adjusted earnings per share skyrocketed more than fivefold to $2.70. Incredibly, management expects revenue growth to accelerate to 170% in the current quarter.
Moreover, analysts continue to lift their long-term growth forecasts for Nvidia and the overall AI industry. "In the last few months, expectations for the rollout of data center AI infrastructure in 2024 about doubled," New Street Research analyst Pierre Ferragu said on Aug. 15. And just days ago, Stifel analyst Ruben Roy said that he "underestimated the opportunity related to the potential shift of $1 trillion of installed data center infrastructure from general purpose compute to accelerated compute architectures."
It's likely that even today, investors are still underestimating Nvidia's ultimate expansion potential. That's presenting you with a chance to buy the semiconductor leader's shares today at a discount to their true value.
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Microsoft, Nvidia, and Palantir Technologies. The Motley Fool has a disclosure policy.
